Thomas J. Schuetz

CIK: 0001591464

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (62.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CMPX

Compass Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

CMPX
Compass Therapeutics, Inc.
Feb 8, 2026
Tax Payment(F)
Direct
36.7K shares at avg. $6.52$239K
CMPX
Compass Therapeutics, Inc.
Jan 9, 2026
Tax Payment(F)
Direct
46.8K shares at avg. $5.35$250K
CMPX
Compass Therapeutics, Inc.
Jan 2, 2026
Award(A)
Direct
250K shares at avg. $5.17$1.3M
CMPX
Compass Therapeutics, Inc.
Nov 16, 2025
Tax Payment(F)
Direct
44K shares at avg. $4.83$213K
CMPX
Compass Therapeutics, Inc.
May 27, 2025
Purchase(P)
Direct
10K shares at avg. $2.11$21K
CMPX
Compass Therapeutics, Inc.
Feb 11, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.5M shares-
CMPX
Compass Therapeutics, Inc.
Feb 8, 2025
Tax Payment(F)
Direct
41.7K shares at avg. $3.50$146K
CMPX
Compass Therapeutics, Inc.
Jan 9, 2025
Tax Payment(F)
Direct
58.1K shares at avg. $1.86$108K

		Type	Shares	Price		Ownership
Feb 8, 2026	CMPX Compass Therapeutics, Inc.	Tax Payment(F)	36,687	$6.52	$239,199	Direct
Jan 9, 2026	CMPX Compass Therapeutics, Inc.	Tax Payment(F)	46,777	$5.35	$250,257	Direct
Jan 2, 2026	CMPX Compass Therapeutics, Inc.	Award(A)	250,000	$5.17	$1,292,500	Direct
Nov 16, 2025	CMPX Compass Therapeutics, Inc.	Tax Payment(F)	44,025	$4.83	$212,641	Direct
May 27, 2025	CMPX Compass Therapeutics, Inc.	Purchase(P)	10,000	$2.11	$21,100	Direct
Feb 11, 2025	CMPX Compass Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	1,500,000	-	-	Direct
Feb 8, 2025	CMPX Compass Therapeutics, Inc.	Tax Payment(F)	41,687	$3.50	$145,905	Direct
Jan 9, 2025	CMPX Compass Therapeutics, Inc.	Tax Payment(F)	58,054	$1.86	$107,980	Direct

1-8 of 8 transactions

About Schuetz Thomas J.

Schuetz Thomas J. (SEC CIK 0001591464) files insider reports with the SEC as CHIEF EXECUTIVE OFFICER of Compass Therapeutics, Inc. (CMPX).

Signal8 holds 8 ownership filings by Schuetz Thomas J., all Form 4s, filed between Jan 13, 2025 and Feb 10, 2026. Those filings report 8 transactions, from Jan 9, 2025 to Feb 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Schuetz Thomas J.'s filings is in BOSTON, MA.

Recent filings by Schuetz Thomas J.

Feb 8, 2026: Tax withholding of CMPX shares (Form 4, code F).
Jan 9, 2026: Tax withholding of CMPX shares (Form 4, code F).
Jan 2, 2026: Grant or award of CMPX shares (Form 4, code A).
Nov 16, 2025: Tax withholding of CMPX shares (Form 4, code F).
May 27, 2025: Open-market purchase of CMPX shares (Form 4, code P).

Other insiders filing for Compass Therapeutics, Inc. (CMPX)

Lerner Neil, Chief Accounting Officer
Anderman Jonathan, General Counsel
Shin Barry, CFO
Sirard Cynthia, Chief Medical Officer
Prasad Arjun, Chief Commercial Officer
LINDAHL RICHARD S, Director

How to read Form 4 transaction codes